Jean-Christophe Marine
#57,763
Most Influential Person Now
Belgian molecular biologist and researcher
Jean-Christophe Marine's AcademicInfluence.com Rankings
Jean-Christophe Marinebiology Degrees
Biology
#4945
World Rank
#7299
Historical Rank
Molecular Biology
#2404
World Rank
#2441
Historical Rank
Download Badge
Biology
Why Is Jean-Christophe Marine Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jean-Christophe Marine is a Belgian molecular biologist and researcher at CME Ku-Leuven . He is head of the VIB Laboratory of Molecular Cancer Biology. His research interest is in the identification and characterization of cancer growth modulators, such as p53.
Jean-Christophe Marine's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (3106)
- SCENIC: Single-cell regulatory network inference and clustering (2017) (1989)
- Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors (1998) (1112)
- Identification of the tumour transition states occurring during EMT (2018) (909)
- The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. (2007) (897)
- iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections (2014) (649)
- Inactivation of the p53 pathway in retinoblastoma (2006) (585)
- SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality (1999) (572)
- Nucleophosmin regulates the stability and transcriptional activity of p53 (2002) (541)
- Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. (2000) (509)
- Interrogating open issues in cancer precision medicine with patient-derived xenografts (2017) (462)
- Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. (2011) (444)
- Melanoma addiction to the long non-coding RNA SAMMSON (2016) (434)
- Toward Minimal Residual Disease-Directed Therapy in Melanoma (2018) (400)
- SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis (1999) (391)
- Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 (2006) (355)
- Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity (2004) (341)
- Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development (2002) (337)
- p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity (2016) (336)
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state (2015) (331)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (323)
- Mdm2-mediated ubiquitylation: p53 and beyond (2010) (309)
- Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice (2008) (295)
- MDM4 is a key therapeutic target in cutaneous melanoma (2012) (289)
- Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. (2006) (273)
- MDMX: from bench to bedside (2007) (238)
- The Ornithine Decarboxylase Gene Is Essential for Cell Survival during Early Murine Development (2001) (232)
- Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death (2010) (232)
- Nucleophosmin Is Required for DNA Integrity and p19Arf Protein Stability (2005) (217)
- Mdmx as an essential regulator of p53 activity. (2005) (206)
- Non-genetic mechanisms of therapeutic resistance in cancer (2020) (201)
- The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice (2014) (200)
- Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. (2000) (200)
- TCTP protects from apoptotic cell death by antagonizing bax function (2008) (192)
- Reciprocal repression between P53 and TCTP (2011) (180)
- Regulation of SIRT6 protein levels by nutrient availability (2008) (178)
- Different levels of Twist1 regulate skin tumor initiation, stemness, and progression. (2015) (178)
- Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression (2014) (169)
- Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo (2010) (167)
- An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. (2010) (165)
- The long noncoding RNA Neat1 is required for mammary gland development and lactation (2014) (162)
- Codon-specific translation reprogramming promotes resistance to targeted therapy (2018) (161)
- Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities (2019) (149)
- An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours (2010) (145)
- GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. (2004) (139)
- A small amphipathic α‐helical region is required for transcriptional activities and proteasome‐dependent turnover of the tyrosine‐phosphorylated Stat5 (2000) (135)
- Clustered organization of homologous KRAB zinc‐finger genes with enhanced expression in human T lymphoid cells. (1993) (132)
- DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation (2005) (130)
- Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion. (2015) (129)
- Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1. (2013) (124)
- dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53 (2005) (123)
- Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. (2016) (120)
- Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma. (2006) (117)
- Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. (2009) (117)
- Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. (2011) (116)
- Evolutionarily Conserved Role of Nucleostemin: Controlling Proliferation of Stem/Progenitor Cells during Early Vertebrate Development (2006) (115)
- Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53 (2003) (114)
- Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia (2019) (107)
- RNF4 is required for DNA double-strand break repair in vivo (2012) (106)
- Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells (2009) (106)
- Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice (2019) (101)
- TPT1/ TCTP-regulated pathways in phenotypic reprogramming. (2013) (97)
- Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma (2020) (94)
- Spotlight on the role of COP1 in tumorigenesis (2012) (93)
- Mdmx and Mdm2: Brothers in Arms? (2004) (88)
- LifeTime and improving European healthcare through cell-based interceptive medicine (2020) (87)
- Non‐coding RNAs: the dark side of nuclear–mitochondrial communication (2017) (85)
- Synthetic lethality between Rb, p53 and Dicer or miR-17–92 in retinal progenitors suppresses retinoblastoma formation (2012) (84)
- Hdmx Recruitment into the Nucleus by Hdm2 Is Essential for Its Ability to Regulate p53 Stability and Transactivation* (2002) (83)
- Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes. (2017) (83)
- p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway (2013) (80)
- Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy (2018) (80)
- Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53. (2016) (79)
- Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death (2006) (79)
- Distinct roles of Mdm2 and Mdm4 in red cell production. (2007) (75)
- Jak3 Selectively Regulates Bax and Bcl-2 Expression To Promote T-Cell Development (2001) (75)
- A Critical Role for p53 in the Control of NF-κB-Dependent Gene Expression in TLR4-Stimulated Dendritic Cells Exposed to Genistein1 (2007) (70)
- c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53* (2009) (68)
- Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3 (2011) (67)
- A non-coding function of TYRP1 mRNA promotes melanoma growth (2017) (65)
- MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output (2010) (64)
- Direct regulation of the Nrarp gene promoter by the Notch signaling pathway. (2004) (63)
- Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma (2018) (60)
- A role for Xenopus Gli-type zinc finger proteins in the early embryonic patterning of mesoderm and neuroectoderm (1997) (58)
- The emerging role of long non‐coding RNAs in cutaneous melanoma (2016) (56)
- The doublesex homolog Dmrt5 is required for the development of the caudomedial cerebral cortex in mammals. (2013) (54)
- Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. (2018) (53)
- Evi1 is specifically expressed in the distal tubule and duct of the Xenopus pronephros and plays a role in its formation. (2006) (53)
- Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma. (2021) (51)
- p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib. (2016) (50)
- The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury. (2015) (50)
- Melanoma models for the next generation of therapies. (2021) (49)
- Cross-species analysis of enhancer logic using deep learning (2020) (46)
- Emergence of the ZNF91 Krüppel-associated box-containing zinc finger gene family in the last common ancestor of anthropoidea. (1995) (45)
- SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation (2018) (43)
- Targeting Mdmx to treat breast cancers with wild-type p53 (2015) (41)
- Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma (2016) (39)
- MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond. (2016) (38)
- MDM2 and MDMX in cancer and development. (2011) (38)
- p53 attenuates AKT signaling by modulating membrane phospholipid composition (2015) (37)
- G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv (2005) (37)
- Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation (2012) (37)
- Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression (2014) (36)
- Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo (2010) (35)
- A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma (2020) (35)
- The long noncoding RNA NEAT1_1 is seemingly dispensable for normal tissue homeostasis and cancer cell growth (2019) (35)
- The Xenopus doublesex-related gene Dmrt5 is required for olfactory placode neurogenesis. (2013) (34)
- The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype (2020) (34)
- Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy. (2015) (34)
- Epithelial‐to‐mesenchymal‐like transition events in melanoma (2021) (31)
- PHGDH heterogeneity potentiates cancer cell dissemination and metastasis (2022) (30)
- The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells (2017) (30)
- NEAT1-containing paraspeckles: Central hubs in stress response and tumor formation (2017) (30)
- MDM4 is a rational target for treating breast cancers with mutant p53 (2017) (30)
- Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma (2017) (29)
- Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma (2017) (29)
- Functional analysis of ZNF85 KRAB zinc finger protein, a member of the highly homologous ZNF91 family. (1998) (28)
- Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming (2019) (28)
- The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids. (2018) (26)
- Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts (2017) (26)
- Apoptosis of Sertoli cells after conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in male sterility (2015) (25)
- p53 stabilization: the importance of nuclear import (2010) (25)
- A cellular hierarchy in melanoma uncouples growth and metastasis (2022) (24)
- Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma (2017) (23)
- Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency (2012) (23)
- Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade. (2016) (23)
- Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas (2015) (22)
- Disseminated Melanoma Cells Transdifferentiate into Endothelial Cells in Intravascular Niches at Metastatic Sites. (2020) (22)
- Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia (2021) (21)
- Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas (2018) (21)
- Integrator restrains paraspeckles assembly by promoting isoform switching of the lncRNA NEAT1 (2020) (19)
- The X-linked trichothiodystrophy-causing gene RNF113A links the spliceosome to cell survival upon DNA damage (2020) (18)
- PTPRV is a Key Mediator of p53-Induced Cell Cycle Exit (2005) (18)
- Targeted chemotherapy overcomes drug resistance in melanoma (2020) (17)
- Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors (2021) (17)
- MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation (2014) (17)
- Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma (2021) (16)
- Long non‐coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation (2021) (15)
- A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression (2022) (15)
- Integrator restrains paraspeckles assembly by promoting isoform switching of the lncRNA NEAT1. (2020) (15)
- Loss of oocytes due to conditional ablation of Murine double minute 2 (Mdm2) gene is p53‐dependent and results in female sterility (2016) (14)
- TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression. (2018) (14)
- Enhanced expression in seminoma of human zinc finger genes located on chromosome 19. (1998) (13)
- Siah2 control of T-regulatory cells limits anti-tumor immunity (2020) (12)
- Pharmacological rescue of p53 in cancer therapy: widening the sensitive tumor spectrum by targeting MDMX. (2010) (12)
- CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance (2021) (11)
- Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients (2015) (11)
- Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop. (2022) (10)
- Single-cell gene regulatory network analysis reveals new melanoma cell states and transition trajectories during phenotype switching (2019) (9)
- IGF2: The Achilles' heel of p53-deficiency? (2012) (9)
- The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival (2021) (8)
- Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice (2014) (8)
- Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine (2021) (7)
- MDM 2 recruitment of lysine methyltransferases regulates p 53 transcriptional output (2010) (7)
- Cross-species analysis of melanoma enhancer logic using deep learning (2019) (6)
- Transforming growth factor-beta and mutant p53 conspire to induce metastasis by antagonizing p63: a (ternary) complex affair (2009) (6)
- Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals (2021) (6)
- Assignment of the human ZNF83 (HPF1) zinc finger gene to chromosome 19q13.3-q13.4. (1994) (5)
- Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value (2021) (5)
- Targeting the MDM 2 / MDM 4 Interaction Interface as a Promising Approach for p 53 Reactivation Therapy (2015) (4)
- Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma (2022) (4)
- A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation (2022) (4)
- Differential roles of cytokine signaling during T-cell development. (1999) (4)
- Dynamic Erasure of Random X-Chromosome Inactivation during iPSC Reprogramming (2019) (4)
- A neural crest stem cell-like state drives nongenetic resistance to targeted therapy in melanoma (2020) (4)
- GSK 3-Mediated BCL-3 Phosphorylation Modulates (2004) (4)
- Translation rewiring at the heart of phenotype switching in melanoma (2017) (4)
- GenisteinTLR4-Stimulated Dendritic Cells Exposed to B-Dependent Gene Expression in k A Critical Role for p53 in the Control of NF-BergheMarine, (2007) (4)
- Using real-time qPCR to evaluate RNAi-mediated gene silencing (2009) (4)
- Heterogeneity in PHGDH protein expression potentiates cancer cell dissemination and metastasis (2021) (4)
- Localization of the human KRAB finger gene ZNF117 (HPF9) to chromosome 7q11.2. (1992) (4)
- Activation of the Integrated Stress Response in drug-tolerant melanoma cells confers vulnerability to mitoribosome-targeting antibiotics (2020) (3)
- Emerging single cell endothelial heterogeneity supports sprouting tumour angiogenesis and growth (2021) (3)
- A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma (2022) (3)
- Degradation Targeting MdmX for Mdm 2-Dependent MdmX at Serine 367 Activates p 53 by DNA Damage-Induced Phosphorylation of (2005) (3)
- Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response (2022) (3)
- Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer (2021) (2)
- Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers (2022) (2)
- Mapping the immune landscape in metastatic melanoma reveals localized cell-cell interactions correlating to immunotherapy responsiveness (2022) (2)
- G 1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p 53 target (2013) (1)
- Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma (2021) (1)
- Gain-of-function CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and therapy-resistance (2020) (1)
- An Integrated Stress Response Pathway activates Perivascular Cancer-Associated Fibroblasts to Drive Angiogenesis and Tumor Progression (2020) (1)
- Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals (2021) (1)
- Mitochondrial determinants of response and resistance to venetoclax plus cytarabine duplet therapy in acute myeloid leukemia (2020) (1)
- Abstract 4338: Tumor reversion: From bench to potential clinical applications using sertraline and thioridazine. (2013) (1)
- Abstract 4730: Inhibition of the p53-HDMX interaction sensitizes melanoma to chemotherapy (2012) (1)
- Abstract 3048: A noncoding function of TYRP1 mRNA promotes melanoma growth (2017) (1)
- Sox 9 Controls Self-Renew al of Oncogene Targeted Cells and Links Tumor Initiation and Invasion Graphical (2015) (1)
- Anticancer immunotherapies transition postcapillary venules into high-endothelial venules that generate TCF1+ T lymphocyte niches through a feed-forward loop (2021) (1)
- Truncal Skin Tumour Development in Mice with Inducible and Conditional Oncogenic BRAF expression and PTEN Deletion Under the Tyrosinase Promoter (2017) (1)
- LifeTime and improving European healthcare through cell-based interceptive medicine (2020) (1)
- T-lymphoid preferential expression of multiple differentially spliced KRAB finger genes clustered on human chromosome 19p12-p13.1. (1992) (1)
- Different Levels of Twist 1 Regulate Skin Tumor Initiation , Stemness , and Progression Graphical (2014) (1)
- Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia (2019) (1)
- Real-time qPCR as a tool for evaluating RNAi-mediated gene silencing (2008) (1)
- Identification of the tumour transition states occurring during EMT (2018) (0)
- Single-cell Genome-and-Transcriptome sequencing without upfront whole-genome amplification reveals cell state plasticity of melanoma subclones (2023) (0)
- Abstract A34: Therapeutic induction of High Endothelial Venules in cancer generates TCF1+ lymphocyte niches (2022) (0)
- Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop. (2023) (0)
- Codon-specific translation reprogramming promotes resistance to targeted therapy (2018) (0)
- Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy (2023) (0)
- 2 F 1-CIP 2 A feedback loop prevents senescence induction in breast cancer cells with inactive p 53 (2012) (0)
- IGF 2 : The Achilles ’ heel of p 53-deficiency ? (2013) (0)
- PHGDH heterogeneity potentiates cancer cell dissemination and metastasis (2022) (0)
- miRNA DYSFUNCTION IN SCHIZOPHRENIA: GENETIC AND FUNCTIONAL EVIDENCE (2008) (0)
- SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response (2022) (0)
- Mdm2 Protects Terminally Differentiated Smooth Muscle Cells from p53-Mediated Cell Death with a Necrotic Morphotype (2006) (0)
- Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine (2021) (0)
- Abstract 2841: A SNP in the 3′-UTR of the MDMX gene is strongly correlated with decreased overall and disease-free survival in ovarian carcinoma patients in an estrogen-receptor-dependent manner (2010) (0)
- Cell position matters for tumour-driving mutations (2022) (0)
- PERK and IRE1 alpha axis of the unfolded protein response contribute to immunogenic cancer cell death (ICD) (2019) (0)
- 686 Recruitment of histone methyltransferases to the p53-MDM2 complex regulates p53 transcriptional output by promoting histone and p53 methylation (2010) (0)
- Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy (2018) (0)
- Siah2 control of T-regulatory cells limits anti-tumor immunity (2020) (0)
- Systems biology of immunogenic cell death in melanoma (2016) (0)
- Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma (2018) (0)
- Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma (2023) (0)
- Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy (2021) (0)
- UC Office of the President Recent Work Title Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma Permalink (2018) (0)
- The lncRNA NEAT1_1 is dispensable for normal tissue homeostasis and cancer cell growth (2019) (0)
- Cancer immunoediting by melanocyte differentiation antigen-specific T cells determines response to immune checkpoint inhibition (2021) (0)
- Chromosomal location of fifteen unique mouse KRAB-containing zinc finger loci (1996) (0)
- Combined CDK and HDAC inhibition induces apoptosis in both uveal and cutaneous melanoma (2016) (0)
- Treatment for giant congenital nevi moves a step closer (2022) (0)
- SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation (2018) (0)
- Identification and functional characterization of lncRNAs in cancer (2013) (0)
- MCT-17-1141 289..300 (2019) (0)
- Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023) (0)
- An oncogenomics-based in vivo screen identifies novel melanoma tumor-suppressors (2016) (0)
- Abstract 103: Dissecting cell state diversity during melanoma growth and metastasis (2023) (0)
- An adverse tumor-protective effect of IDO1 inhibition (2023) (0)
- Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110]. (2022) (0)
- Regulation of the tumor suppressor p53 by Mdm2 and Mdm4 (2007) (0)
- Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy (2021) (0)
- Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis (2022) (0)
- Cell position matters in tumour development (2022) (0)
- High-throughput lncRNA expression profiling identifies candidate cancer lncRNAs (2013) (0)
- TUMOR ENDOTHELIAL CELL AUTOPHAGY IS A KEY VASCULAR-IMMUNE CHECKPOINT IN MELANOMA (2023) (0)
- L’expérimentation animale reste indispensable (OPINION) (2017) (0)
- Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis (2020) (0)
- 384 Dicer1 is a synthetic lethal partner of tumour suppressor p53 (2010) (0)
- Correction for Danovi et al., “Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity” (2019) (0)
- Author Correction: A cellular hierarchy in melanoma uncouples growth and metastasis (2022) (0)
- The X-linked trichothiodystrophy-causing gene RNF113A links the spliceosome to cell survival upon DNA damage (2020) (0)
This paper list is powered by the following services:
Other Resources About Jean-Christophe Marine
What Schools Are Affiliated With Jean-Christophe Marine?
Jean-Christophe Marine is affiliated with the following schools:
